CNTG
$9.63
Centogene N.V.
$.27
2.88%
CNTG
Earnings Whisper ®
N/A
3rd Quarter September 2020
Consensus:  ($0.33)
Revenue:  N/A
Wednesday
Dec 23
6:30 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch
Guidance announcement made Wednesday, September 23, 2020
Latest EPS
Wednesday, September 23, 2020

What do you expect when CNTG reports earnings?
Beat
Meet
Miss

Where is CNTG's stock price going from here?
Up
Flat
Down
Stock chart of CNTG
Analysts
Summary of analysts' recommendations for CNTG
Score
Grade
Pivots
Resistance
$10.69
$10.44
$10.04

$9.79

Support
$9.39
$9.14
$8.74
Tweet
Growth
Description
Centogene is a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians and pharmaceutical companies. The Company?s goal is to bring rationality to treatment decisions and to accelerate the development of new orphan drugs by using their knowledge of the global rare disease market, including epidemiological and clinical data and innovative biomarkers.